Involvement of 26-kDa Cell-Associated TNF-α in Experimental Hepatitis and Exacerbation of Liver Injury with a Matrix Metalloproteinase Inhibitor

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 414-419

  Solorzano, Carmen C ^a   Ksontini, Riadh ^a   Pruitt, Jeffrey H ^a   Hess, Philip J ^a   Edwards, Paul D ^a   Kaibara, Atsushi ^a   Abouhamze, Amer ^a   Auffenberg, Troy ^a   Galardy, Richard E ^c   Vauthey, J Nicolas ^a   Copeland III, Edward M ^a   Edwards III, Carl K ^b   Lauwers, Gregory Y ^a   Clare Salzler, Michael ^a   MacKay, Sally L D ^a   Moldawer, Lyle L ^a   Lazarus, Douglas D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b AMGEN INC   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; DIPEPTIDE; GALACTOSAMINE; ILOMASTAT; LIPOPOLYSACCHARIDE; METALLOPROTEINASE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; INJURY; LIVER; MORTALITY; MOUSE; PATHOLOGY; TOXIC HEPATITIS;

ANIMALS; CONCANAVALIN A; DIPEPTIDES; DRUG SYNERGISM; GALACTOSAMINE; HEPATITIS, TOXIC; LIPOPOLYSACCHARIDES; LIVER; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030638944     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
2. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. M. Clements, M. Crimmin, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1995. Matrix metalloproteinases and processing of pro-TNF-α. J. Leukocyte Biol. 57:774.
3. Gearing, A. J. H., P. Beckett, M. Christodoulou, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. N. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555.
4. McGeehan, G. M., J. D. Becherer, R. C. Bast, Jr., C. M. Boyer, B. Champion, K. M. Connolly, J. G. Conway, P. Furdon, S. Karp, S. Kidao, A. B. McElroy, J. Nichols, K. M. Pryzwansky, F. Schoenen, L. Sekut, A. Truesdale, M. Verghese, J. Warner, and J. P. Ways. 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370:558.
5. Mohler, K. M., P. M. Sleath, J. N. Fitzner, D. P. Ceretti, M. Alderson, S. S. Kerwar, D. S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, S. Kronheim, M. Petersen, M. Gerhart, C. J. Kozlosky, C. J. March, and R. A. Black. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218.
6. Grobelny, D., L. Poncz, and R. E. Galardy. 1991. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aerugenosa elastase by peptide hydroxamic acids. Biochemistry 31:7152.
7. Gijbels, K., R. Galardy, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94:2177.
8. Schultz, G. S., S. Strelow, G. A. Stern, N. Chegini, M. B. Grant, R. E. Galardy, D. Grobelny, J. J. Rowsey, K. Stonecipher, V. Parmley, and P. Khaw. 1992. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 33:3325.
9. Russell, D. A., K. K. Tucker, N. Chinookoswong, R. C. Thompson, and T. Kohno. 1995. Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function. J. Infect. Dis. 171:1528.
10. Espat, N. J., J. C. Cendan, E. A. Beierle, T. Auffenberg, J. Rosenberg, D. Russell, J. S. Kenney, E. Fischer, W. Montegut, S. F. Lowry, E. M. Copeland III, and L. L. Moldawer. 1995. PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J. Surg. Res. 59: 153.
11. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:4845.
12. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
13. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1529.
14. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and G. Tiros. 1995. Concanavalin A-induced T-cell mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190.
15. Maeda, T., K. Balakrishnan, and S. Q. Mehdi. 1983. A simple and rapid method for the preparation of plasma membranes. Biochim. Biophys. Acta 731:115.
16. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopolous, W. Lesslauer, G. Kollias, K. Pfizenmaler, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80-kDa tumor necrosis factor receptor. Cell 83:793.
17. Bigda, J., I. Beletsky, C. Brakebusch, Y. Varfolomeev, H. Engelmann, H. Holtmann, and D. Wallach. 1994. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180:445.
18. Marian, S. M., B. Matiba, C. Baumler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25:2303.
19. Crowe, P. D., B. N. Walter, K. M. Mohler, C. O. Evans, R. A. Black, and C. F. Ware. 1995. A metalloprotease inhibitor blocks shedding ot the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1201.
20. Van der Poll, T., and S. F. Lowry. 1995. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense. Shock 3:1.
21. Bicknell, G. R., and G. M. Cohen. 1995. Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem. Biophys. Res. Commun. 207:40.
22. Cohen, G. M., X. M. Sun, R. T. Snowden, D. Dinsdale, and D. N. Skilleter. 1992. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:331.
23. Collins, R. J., B. V. Harmon, G. C. Gobe, and J. F. Kerr. 1992. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61:451.